NASDAQ

Opus Genetics, Inc. (IRD)

♥ 533 Thanks from members

Live price chart, market sentiment, and community perspectives for Opus Genetics, Inc. (NASDAQ: IRD).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: Health CareIndustry: BiotechnologyFounder: Shannon BoyeFounder: Jean BennettLeadership: Lucie Ghanem (CEO)Holder: OcugenHolder: Fidelity ManagementHolder: Vanguard GroupOcular Gene TherapiesAAV-based Therapeutics#IRD#Opus Genetics#Biotech#Gene Therapy#NASDAQ